A landmark 2019 first-in-human clinical trial showed that daily pasteurized Akkermansia MucT supplementation supported healthy insulin function in overweight individuals
Secondly, given the prevalence of conditions such as obesity and overweight, high blood glucose, cholesterol, and triglyceride levels, there was a need to explore alternative and potentially effective interventions beyond traditional medications. In the study, the researchers assigned 120 Lebanese participants (mean age, 17 years) with overweight or obesity to intervention groups receiving either 5 mL, 10 mL or 15 mL of ACV daily or to a control group over a 12-week period
Because no publicly validated stability data exist for the reconstituted solution, all storage instructions including temperature, beyond-use date, and handling must come exclusively from the trial sponsor's pharmacy manual or the IMP label supplied with your preparation
Patients should review most current information about platform compliance and regulatory standing before treatment
